Weight loss surgery and liraglutide study on thinking and long-term weight
Part of Hormones & metabolism clinical trials.
This trial tests whether bariatric surgery or the drug liraglutide helps people with obesity lose weight and keep it off by looking at how it affects your thinking and behavior. It might help you understand which treatment works best for long-term success.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 60 years old.
- You have a body mass index (BMI) of 30 or higher.
- You have no history of serious brain or mental health problems.
- You are scheduled for weight loss surgery, treatment with liraglutide, or a doctor-recommended diet plan.
- You are willing to follow all study procedures and sign a consent form.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing two weight-loss medications: liraglutide alone or combined with orlistat. It is for adults who are overweight or obese and have certain related health conditions like high blood pressure or type 2 diabetes. The goal is to see which treatment works better for long-term weight loss.
This study tests whether taking a medication called liraglutide (Saxenda) before weight-loss surgery, along with a special diet, helps people lose more weight than just the diet alone. It may help you prepare for surgery and improve your results.
This trial tests whether a medication (liraglutide) plus behavioral counseling helps people with severe obesity and binge-eating disorder reduce binge episodes, lose weight, and improve coping. Participants will receive either liraglutide or placebo, along with group therapy sessions.
This study tests whether a medication that helps with weight loss, called a GLP-1 agonist, can also change how the brain works. It is for teenagers (12-18) and adults (30-45) with obesity.
This study examines how semaglutide (a weight loss injection) affects brain function and blood vessel health in people with obesity. Researchers will compare brain scans and blood vessel measurements before and after treatment to understand whether weight loss improves thinking and memory.
This trial tests whether combining a GLP-1 medication (a type of diabetes drug that also helps with weight loss) with an exercise program can improve physical function in people with obesity. If you are obese and have trouble with daily activities, this study may help you become more mobile and healthier.
Hear when a new Obesity and Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.